Impact of Intraoperative ICG on Functional Outc in RARP
Part of paid clinical trials in Orange, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT06446648
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Prostate Adenocarcinoma
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ICG — DRUGAdminister an IV ICG injection intraoperatively, using the optimal dosage and timing defined in the second phase of the study. Utilize the newly developed 3D vascular map for visualization of the arteries before and after prostate resection.
Study Details
This is a pilot, 3 phases open-label feasibility study with the 3rd phase consisting of randomized 2-arm intervention trial, to assess the systematic use of indocyanine green (ICG) in subjects with prostate adenocarcinoma during robot-assisted radical prostatectomy and its impact on sexual function outcomes at 12 months postoperatively.
Key Dates
- Start date
- Jul 12, 2024
- Status verified
- Feb 2026
- Primary completion
- Jul 31, 2028
- Completion
- Jul 31, 2030
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- No Intervention: SOC groupRobot-Assisted Radical Prostatectomy will be performed as a standard procedure.
- Experimental: ICG groupRobot-Assisted Radical Prostatectomy using ICG
Primary Outcome Measure
Continence Rate at 3 month Post-surgery [ Time Frame: 3 months ]
Central Contacts
- Chao Family Comprehensive Cancer Center University of California, Irvine1-877-827-8839
- University of California Irvine Medical
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Chao Family Comprehensive Cancer Center University of California, Irvine | Orange | California | 92868 |
Find similar trials in Orange, CA
Related Studies
- Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical ProstatectomyPHASE2 · Recruiting · David Oh · San Francisco, California
- Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active SurveillancePHASE2 · Recruiting · University of California, San Francisco · San Francisco, California
- Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialPHASE3 · Recruiting · NRG Oncology · Phoenix, Arizona
- Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingPHASE3 · Recruiting · ECOG-ACRIN Cancer Research Group · Anchorage, Alaska